Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma

Oncology Reports

Volumn 22, Issue 5, 2009, Pages 1045-1050

  Kawasoe, Yasuomi ^a   Yokouchi, Masahiro ^a   Ueno, Yoshinori ^a   Iwaya, Hiroaki ^a   Yoshida, Hiroki ^a   Komiya, Setsuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Hyperbaric oxygen; Lung metastasis; Osteosarcoma

Indexed keywords

CARBOPLATIN; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER MORTALITY; CANCER SURVIVAL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HYPERBARIC OXYGEN; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MONOTHERAPY; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BONE NEOPLASMS; CARBOPLATIN; CELL PROLIFERATION; CHEMOTHERAPY, ADJUVANT; DRUG SYNERGISM; FEMALE; HYPERBARIC OXYGENATION; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MICE; MICE, INBRED C3H; OSTEOSARCOMA; TUMOR CELLS, CULTURED;

EID: 70449347045     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000534     Document Type: Article

References (38)

1. Dorfman HD and Czerniak B: Bone cancers. Cancer 7: 203-210, 1995.
2. Whelan JS: Osteosarcoma. Eur J Cancer 33: 1611-1619, 1997.
3. Meyers PA and Gorlick R: Osteosarcoma. Pediatr Clin North Am 44: 973-989, 1997.
4. Bramwell VH: The role of chemotherapy in the management of non-metastatic operable extremity osteosarcoma. Semin Oncol 24: 561-571, 1997.
5. Daruwalla J and Christophi C: Hyperbaric oxygen therapy for malignancy: a review. World J Surg 30: 2112-2131, 1997.
6. Bush RS, Jenkin RD, Allt WE, et al: Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 3: 302-306, 1978.
7. Brown JM: Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol 52: 650-656, 1979.
8. Teicher BA, Lazo JS and Sartorelli AC: Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41: 73-81, 1981.
9. Graeber TG, Osmanian C, Jacks T, et al: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91, 1996.
10. Yang QC, Zeng BF, Dong Y, et al: Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome. Jpn J Clin Oncol 37: 127-134, 2007.
11. Vukovic V, Haugland HK, Nicklee T, et al: Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res 61: 7394-7398, 2001.
12. Sheffield PJ: Measuring tissue oxygen tension: a review. Undersea Hyperb Med 25: 179-188, 1998.
13. Shewell J and Thompson SC: The effect of hyperbaric oxygen treatment on pulmonary metastasis in the C3H mouse. Eur J Cancer 16: 253-259, 1980.
14. Valaitis j, Van Elk J and Staley CJ: Effect of hyperbaric oxygen and nitrogen mustard (NSC-762) on Ehrlich ascites tumor. Cancer Chemother Rep 52: 405-412, 1968.
15. DeCosse JJ and Rogers LS: Influence of high-pressure oxygen and chemotherapy on the AMel 4 hamster melanoma. Cancer Res 26: 287-292, 1966.
16. Dettmer CM, Kramer S, Gottlieb SF, Aponte GE and Driscoll DH: The effect of increased oxygen tensions upon animal tumor growth. Am J Roentgenol Radium Ther Nucl Med 102: 804-810, 1968.
17. Feldmeier J, Carl U, Hartmann K and Sminia P: Hyperbaric oxygen: does it promote growth or recurrence of malignancy? Undersea Hyperb Med 30: 1-18, 2003.
18. Asai T, Ueda T, Itoh K, et al: Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 76: 418-422, 1998.
19. Hiraoka K, Zenmyo M, Komiya S, et al: Relationship of p21 (waf1/ cip1) and differentiation in chondrosarcoma cells. Virchows Arch 440: 285-290, 2002.
20. Teicher BA, Herman TS, Holden SA, Epelbaum R, Liu SD and Frei E III: Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. Cancer Res 51: 780-784, 1991.
21. Nakamura S, Kashimoto S, Kajikawa F and Nakata K: Combination effect of recombinant human interleukin 1 alpha with antitumor drugs on syngeneic tumors in mice. Cancer Res 51: 215-221, 1991.
22. 60Co therapy and hyperbaric oxygen. Proc Third Int Congress Hyperbaric Med, pp648-652, 1966.
23. Cade IS and McEwen JB: Megavoltage radiotherapy in hyperbaric oxygen. A controlled trial. Cancer 20: 817-821, 1967.
24. Henk JM: Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensitizers? Int J Radiat Oncol Biol Phys 12: 1339-1341, 1986.
25. Takiguchi N, Saito N, Nunomura M, et al: Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in individual organs. Cancer Chemother Pharmacol 47: 11-14, 2001.
26. Petre PM, Baciewicz FA Jr, Tigan S and Spears JR: Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of metastatic lung tumors in a rat model. J Thorac Cardiovasc Surg 125: 85-95, 2003.
27. Martin DF, Porter EA, Rockwell S and Fischer JJ: Enhancement of tumor radiation response by the combination of a perfluorochemical emulsion and hyperbaric oxygen. Int J Radiat Oncol Biol Phys 13: 747-751, 1987.
28. Lian QL, Hang RC, Yan HF, et al: Effects of hyperbaric oxygen on S-180 sarcoma in mice. Undersea Hyperb Med 22: 153-160, 1995.
29. Conconi MT, Baiguera S, Guidolin D, et al: Effects of hyperbaric oxygen on proliferative and apoptotic activities and reactive oxygen species generation in mouse fibroblast 3T3/J2 cell line. J Investig Med 51: 227-232, 2003.
30. Raa A, Stansberg C, Steen VM, Bjerkvig R, Reed RK and Stuhr LE: Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumors. BMC Cancer 7: 23, 2007.
31. Chen YC, Chen SY, Ho PS, et al: Apoptosis of T-leukemia and B-myeloma cancer cells induced by hyperbaric oxygen increased phosphorylation of p38 MAPK. Leuk Res 31: 805-815, 2007.
32. Stuhr LE, Raa A, Oyan AM, et al: Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. J Neurooncol 85: 191-202, 2007.
33. Lash GE, Postovit LM, Matthews NE, et al: Oxygen as a regulator of cellular phenotypes in pregnancy and cancer. Can J Physiol Pharmacol 80: 103-109, 2002.
34. Feldmeier JJ, Onoda JM, Bossung DE, Court WS and Alecu R: Effect of Hyperbaric oxygen on cancer cell metastatic potential and proliferation. Undersea Hyper Med 24: 125, 1997.
35. Stuhr LE, Iversen VV, Straume O, Maehle BO and Reed RK: Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors. Cancer Lett 210: 35-40, 2004.
36. Kalns J, Krock L and Piepmeier E Jr: The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. Anticancer Res 18: 363-367, 1998.
37. Sealy R, Cridland S, Barry L and Norris R: Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 12: 1343-1346, 1986.
38. Postovit LM, Adams MA, Lash GE, Heaton JP and Graham CH: Oxygen-mediated regulation of tumor cell invasiveness. Involvement of a nitric oxide signaling pathway. J Biol Chem 277: 35730-35737, 2002.